Sonnet BioTherapeutics I...

NASDAQ: SONN · Real-Time Price · USD
3.53
-0.23 (-6.12%)
At close: Aug 15, 2025, 3:59 PM
3.50
-0.85%
After-hours: Aug 15, 2025, 06:13 PM EDT

Sonnet BioTherapeutics Ratios and Metrics

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
PE Ratio
-0.59 -0.16 -0.21 -0.59
PEG Ratio
0.01 0.00 0.00 0.01
PS Ratio
235.35 20.12 18.25 30.73
PB Ratio
-9.02 -13.16 -2.52 0.67
P/FCF Ratio
-0.51 -0.14 -0.22 -0.66
P/OCF Ratio
-0.51 -0.14 -0.23 -0.66
OCF/S Ratio
-462.13 -144.39 -79.12 -46.63
Debt / Equity Ratio
-0.27 -0.9 -0.1 0.01
Quick Ratio
0.66 0.86 0.66 4.30
Current Ratio
0.66 0.86 0.66 4.30
Asset Turnover
0.01 0.03 0.06 0.02
Interest Coverage
n/a n/a n/a n/a
Return on Equity
15.31 83.34 11.73 -1.12
Return on Assets
-2.68 -3.47 -5.11 -0.86
Return on Invested Capital
33.39 -368.63 13.02 -1.12
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 -60.28 0.80
Net Profit Margin
-399.29 -127.42 -85.08 -51.71
Pretax Profit Margin
-399.29 -127.42 -84.93 -51.66
Operating Profit Margin
-636.18 -127.14 -84.78 -51.87
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-631.72 -126.63 -84.52 -51.68